Death by histone deacetylase inhibitor quisinostat in tongue squamous cell carcinoma via apoptosis, pyroptosis, and ferroptosis. 2021

Xinhuan Wang, and Ke Liu, and Huimin Gong, and Dezhi Li, and Wenfeng Chu, and Dan Zhao, and Xiaofeng Wang, and Dongyang Xu
Department of Oral and Maxillofacial Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, PR China.

Tongue cancer is one of the most common oral malignancies. Quisinostat is a histone deacetylase inhibitor with antitumor activity. The aim of this study was to evaluate the effects of quisinostat on the viability of tongue squamous cell carcinoma (TSCC) cells (CAL-27, TCA-8113) in vitro and in vivo. Cell viability, cell morphological observation, scratch wound-healing assay, transwell migration assay, transmission electron microscope, flow cytometry and cellular reactive oxygen species were assessed in vitro. The results showed that quisinostat can significantly inhibit the viability, growth and migration of TSCC cells. And quisinostat could significantly induce TSCC cells apoptosis, pyroptosis, and ferroptosis. Quisinostat significantly inhibited tumor tissue growth in animal experiments. Up-regulation of the expression of Bax, cleaved-caspase3, caspase-1, p53, phospho-p53 and down-regulated of the expression of caspase-3, Bcl-2, GPX4 in cell lines and tumor tissues of nude mice were observed by Western blotting analysis. Up-regulation of the expression of caspase-1, Bax, cleaved-caspase3, p53 and down-regulated of the expression of ki67, caspase-3, Bcl-2, GPX4 in tumor tissues of nude mice were observed by immunohistochemistry. TUNEL analysis showed that quisinostat could increase the apoptosis rate in the tumor tissues of nude mice. Up-regulation of the expression of p53 and down-regulated expression of GPX4 in cell lines were observed by immunofluorescent staining, and the expression locations of p53 and GPX4 proteins in TSCC cells were observed. Based on these findings, quisinostat may be a potential drug for the treatment of tongue squamous cell carcinoma.

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006877 Hydroxamic Acids A class of weak acids with the general formula R-CONHOH. Hydroxamic Acid,Acid, Hydroxamic,Acids, Hydroxamic
D000069292 Pyroptosis Type of programmed cell death associated with infection by intracellular pathogens. It is characterized by INFLAMMASOME formation; activation of CASPASE 1; and CYTOKINES mediated inflammation. Caspase-1 Dependent Cell Death,Inflammatory Apoptosis,Pyroptotic Cell Death,Apoptoses, Inflammatory,Apoptosis, Inflammatory,Caspase 1 Dependent Cell Death,Cell Death, Pyroptotic,Cell Deaths, Pyroptotic,Death, Pyroptotic Cell,Deaths, Pyroptotic Cell,Inflammatory Apoptoses,Pyroptoses,Pyroptotic Cell Deaths
D000079403 Ferroptosis A form of REGULATED CELL DEATH initiated by oxidative perturbations of the intracellular microenvironment that is under constitutive control by glutathione peroxidase 4 and can be inhibited by iron chelators and lipophilic antioxidants. Oxytosis
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014062 Tongue Neoplasms Tumors or cancer of the TONGUE. Cancer of Tongue,Tongue Cancer,Cancer of the Tongue,Neoplasms, Tongue,Cancer, Tongue,Cancers, Tongue,Neoplasm, Tongue,Tongue Cancers,Tongue Neoplasm

Related Publications

Xinhuan Wang, and Ke Liu, and Huimin Gong, and Dezhi Li, and Wenfeng Chu, and Dan Zhao, and Xiaofeng Wang, and Dongyang Xu
August 2019, Investigational new drugs,
Xinhuan Wang, and Ke Liu, and Huimin Gong, and Dezhi Li, and Wenfeng Chu, and Dan Zhao, and Xiaofeng Wang, and Dongyang Xu
October 2021, Investigational new drugs,
Xinhuan Wang, and Ke Liu, and Huimin Gong, and Dezhi Li, and Wenfeng Chu, and Dan Zhao, and Xiaofeng Wang, and Dongyang Xu
July 2010, Molecular cancer therapeutics,
Xinhuan Wang, and Ke Liu, and Huimin Gong, and Dezhi Li, and Wenfeng Chu, and Dan Zhao, and Xiaofeng Wang, and Dongyang Xu
July 2018, International journal of oncology,
Xinhuan Wang, and Ke Liu, and Huimin Gong, and Dezhi Li, and Wenfeng Chu, and Dan Zhao, and Xiaofeng Wang, and Dongyang Xu
March 2024, Parasite immunology,
Xinhuan Wang, and Ke Liu, and Huimin Gong, and Dezhi Li, and Wenfeng Chu, and Dan Zhao, and Xiaofeng Wang, and Dongyang Xu
June 2012, International journal of oncology,
Xinhuan Wang, and Ke Liu, and Huimin Gong, and Dezhi Li, and Wenfeng Chu, and Dan Zhao, and Xiaofeng Wang, and Dongyang Xu
January 2022, JAMA dermatology,
Xinhuan Wang, and Ke Liu, and Huimin Gong, and Dezhi Li, and Wenfeng Chu, and Dan Zhao, and Xiaofeng Wang, and Dongyang Xu
November 2019, International immunopharmacology,
Xinhuan Wang, and Ke Liu, and Huimin Gong, and Dezhi Li, and Wenfeng Chu, and Dan Zhao, and Xiaofeng Wang, and Dongyang Xu
January 2015, Expert opinion on investigational drugs,
Xinhuan Wang, and Ke Liu, and Huimin Gong, and Dezhi Li, and Wenfeng Chu, and Dan Zhao, and Xiaofeng Wang, and Dongyang Xu
September 2018, International journal of molecular sciences,
Copied contents to your clipboard!